deltatrials
Recruiting NA INTERVENTIONAL 2-arm NCT06068075

Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD

Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: The LEOPARD Study

Sponsor: Alex's Lemonade Stand Foundation

Updated 6 times since 2023 Last updated: Jan 21, 2026 Started: May 8, 2018 Primary completion: Jan 1, 2027 Completion: Jan 1, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06068075, this NA trial focuses on Ewing Sarcoma and Ewing Sarcoma of Bone and remains actively recruiting participants. Sponsored by Alex's Lemonade Stand Foundation, it has been updated 6 times since 2018, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshotRecruiting~Dec 2024 – ~Feb 2025 · 2 months · monthly snapshot~Feb 2025 – ~Feb 2026 · 12 months · monthly snapshotRecruiting~Feb 2026 – present · 5 months · monthly snapshotRecruiting

Change History

6 versions recorded
  1. Feb 2026 — Present [monthly]

    Recruiting NA

  2. Feb 2025 — Feb 2026 [monthly]

    Recruiting NA

  3. Dec 2024 — Feb 2025 [monthly]

    Recruiting NA

  4. Sep 2024 — Dec 2024 [monthly]

    Recruiting NA

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

Show 1 earlier version
  1. Nov 2023 — Jul 2024 [monthly]

    Recruiting NA

    First recorded

May 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Alex's Lemonade Stand Foundation
  • Conquer Cancer Foundation
  • Dana-Farber Cancer Institute
  • Harvard University
  • Sam Day Foundation
Data source: Dana-Farber Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .